This study analyzed over 80 PCR validations—66 with extraction data—across 11 biological matrices using three platforms (easyMAG, KingFisher, QIAgen). It assessed precision and limit of detection (LoD) for qPCR, RT-qPCR, and ddPCR.
Acellular matrices (e.g., plasma, urine) showed better precision and lower LoDs than cellular matrices.
easyMAG performed best with acellular samples; QIAgen was most effective with cellular ones.
KingFisher achieved the lowest average LoDs due to higher nucleic acid input.
ddPCR in PBMCs showed improved precision, though LoD varied.
Conclusion:
Pairing the right matrix with the appropriate extraction platform is crucial for reliable PCR-based bioanalysis in drug development.